文献速递牙体牙髓病

新型与传统根管内药物对生物膜活性及组成的影响

Effect of Novel and Traditional Intracanal Medicaments on Biofilm Viability and Composition.
PubMed 文献 · J Endod · 2024-07-15

本研究为三部分体外实验,先确定能显著降低粪肠球菌和纳氏放线菌生物膜生物量的D-氨基酸浓度,再表征反式肉桂醛联合D-氨基酸对多菌种生物膜的作用,最后与氢氧化钙及未处理对照比较。结果显示反式肉桂醛(0.06%)联合D-酪氨酸(1 mM)和D-色氨酸(25 mM)显著降低生物膜生物量和活性,其杀菌百分比和基质减少程度优于氢氧化钙。

要点

  • 反式肉桂醛联合D-酪氨酸和D-色氨酸可显著降低多菌种生物膜生物量和活性。
  • 该组合的杀菌效果和基质减少程度优于氢氧化钙。
  • 该组合有潜力开发为根管内药物。

核心结论

  • 反式肉桂醛联合D-酪氨酸和D-色氨酸的抗菌膜活性优于氢氧化钙,有潜力开发为根管内药物。

研究设计与样本

  • 三部分体外研究:先确定D-氨基酸浓度,再表征反式肉桂醛联合D-氨基酸对多菌种生物膜的作用,最后与氢氧化钙和未处理对照比较。

主要发现

  • 反式肉桂醛(0.06%)联合D-酪氨酸(1 mM)和D-色氨酸(25 mM)较对照显著降低生物膜生物量和活性(P < .05)。
  • 反式肉桂醛联合D-氨基酸与氢氧化钙在可培养细菌计数上无显著差异(P > .05)。
  • 共聚焦显微镜显示反式肉桂醛联合D-氨基酸处理组死菌百分比显著高于氢氧化钙和对照(P < .05)。
  • 反式肉桂醛联合D-氨基酸显著降低生物膜生物体积和所有检测的基质成分,氢氧化钙仅显著降低胞外多糖量(P < .05)。

临床怎么用

  • 反式肉桂醛联合D-酪氨酸和D-色氨酸可作为潜在根管内药物,其抗菌膜效果优于氢氧化钙。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The aim of this study was to test the hypothesis that a combination of D-amino acids (DAAs) and trans-cinnamaldehyde (TC) demonstrates superior antibiofilm activity to calcium hydroxide (CH) and untreated controls. METHODS: In this 3-part in vitro study, the concentration of DAAs (D-methionine, D-leucine, D-tyrosine, and D-tryptophan) that would significantly decrease Enterococcus faecalis and Actinomyces naeslundii biofilm biomass was first determined. Then, the effect of TC + selected DAAs on polymicrobial biofilms was characterized by quantifying the biomass and biofilm viability. Finally, the antibiofilm effects of TC + DAA was compared with CH and untreated controls by (i) determining bacterial viability and (ii) quantifying biofilm matrix composition using selective fluorescence-binding analysis. Statistical analysis was performed using one-way ANOVA and appropriate multiple comparisons test, with P < .05 considered as statistically significant. RESULTS: TC (0.06%) + D-tyrosine (1 mM) + D-tryptophan (25 mM) significantly reduced the biomass and biofilm viability compared to the control (P < .05). While no significant difference was observed between TC + DAA and CH in the cultivable bacterial counts (P > .05), confocal microscopy demonstrated a significantly greater percentage of dead bacteria in TC + DAA-treated biofilms compared to CH and the control (P < .05). TC + DAA significantly decreased the biovolume and all the examined components of the biofilm matrix quantity compared to the control, while CH significantly reduced only the exopolysaccharide quantity (P < .05). CONCLUSION: The combination of TC + D-tyrosine + D-tryptophan demonstrated superior antibiofilm activity (biofilm bacterial killing and reduction of matrix quantity) to CH and has potential to be developed as an intracanal medicament.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Siu SY, Pudipeddi A, Vishwanath V, et al. Effect of Novel and Traditional Intracanal Medicaments on Biofilm Viability and Composition. J Endod. 2024. PMID: 39019323. doi:10.1016/j.joen.2024.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。